Human Adipose Tissue Derived Pericytes Increase Life Span in Utrn tm1Ked Dmd mdx/J Mice

Stem Cell Reviews and Reports

Volumn 10, Issue 6, 2014, Pages 830-840

  Valadares, M C ^a   Gomes, J P ^a   Castello, G ^a   Assoni, A ^a   Pellati, M ^a   Bueno, C ^a   Corselli, M ^b   Silva, H ^c   Bartolini, P ^d   Vainzof, M ^a   Margarido, P F ^a   Baracat, E ^a   Peault B ^b   Zatz, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b JOINT REPLACEMENT INSTITUTE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Adipose Tissue; DMD; Life Span; Pericytes; Stem Cells

Indexed keywords

DYSTROPHIN;

ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; DISEASE MODEL; FEMALE; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; MOUSE; MUSCULAR DYSTROPHY, DUCHENNE; PERICYTE; PHYSIOLOGY; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DYSTROPHIN; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED MDX; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PERICYTES;

EID: 84929299586     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-014-9537-9     Document Type: Article

References (35)

1. Mercuri, E. (2013). Muntoni F. Lancet: Muscular dystrophies.
2. Manzur A, Kuntzer T, Pike M et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane database of systematic reviews (Online). 2008.
3. Biggar, W., Harris, V., Eliasoph, L., et al. (2006). Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscular disorders: NMD., 16, 249–255.
4. Partridge, T. (1991). Animal models of muscular dystrophy–what can they teach us? Neuropathology and applied neurobiology., 17, 353–363.
5. Deconinck, A., Rafael, J., Skinner, J., et al. (1997). Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell., 90, 717–727.
6. Lazarus, H., Haynesworth, S., Gerson, S., et al. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone marrow transplantation., 16, 557–564.
7. Caplan, A., & Dennis, J. (2006). Mesenchymal stem cells as trophic mediators. Journal of cellular biochemistry., 98, 1076–1084.
8. Le Blanc, K., Tammik, L., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian journal of immunology., 57, 11–20.
9. Gao, J., Dennis, J., Muzic, R., et al. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells, tissues, organs., 169, 12–20.
10. Crisan, M., Yap, S., Casteilla, L., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. CELL STEM CELL., 3, 301–313.
11. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature cell biology., 9, 255–267.
12. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell., 131, 324–336.
13. Caplan, A. (2008). All MSCs are pericytes? Cell stem cell., 3, 229–230.
14. de la Garza-Rodea, A., van der Velde-van, D. I., Boersma, H., et al. (2012). Myogenic properties of human mesenchymal stem cells derived from three different sources. Cell transplantation., 21, 153–173.
15. Kennel, P., Fonteneau, P., Martin, E., et al. (1996). Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiology of disease., 3, 137–147.
16. Alcoser, S., Kimmel, D., Borgel, S., et al. (2011). Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC biotechnology., 11, 124.
17. Song, P., Xie, Z., Guo, L., et al. (2012). Human genome-specific real-time PCR method for sensitive detection and reproducible quantitation of human cells in mice. Stem cell reviews., 8, 1155–1162.
18. Mesa, L., Dubrovsky, A., Corderi, J., et al. (1991). Steroids in Duchenne muscular dystrophy–deflazacort trial. Neuromuscular disorders: NMD., 1, 261–266.
19. Angelini, C., Pegoraro, E., Turella, E., et al. (1994). Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle & nerve., 17, 386–391.
20. Kinali M, Mercuri E, Main M et al. An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscular disorders: NMD. 2002;12 Suppl 1:74.
21. Zucconi, E. (2011). Vieira NM. Jr. et al. Preclinical Studies with Umbilical Cord Mesenchymal Stromal Cells in Different Animal Models for Muscular Dystrophy. Journal of Biomedicine and Biotechnology: Bueno CR.
22. Vieira N, Bueno C, Brandalise V et al. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem cells (Dayton, Ohio). 2008;26:2391–2398.
23. Pittenger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science (New York, NY). 1999;284:143–147.
24. Huang, G. (2009). Gronthos S. Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. Journal of dental research., 88, 792–806.
25. Zuk, P., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell., 13, 4279–4295.
26. Lee, D.-H., Joo, S.-D., Han, S.-B., et al. (2011). Isolation and expansion of synovial CD34 (−) CD44 (+) CD90 (+) mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique. Connective tissue research., 52, 226–234.
27. Secco, M., Moreira, Y., Zucconi, E., et al. (2009). Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem cell reviews., 5, 387–401.
28. Rossignoli, F., Caselli, A., Grisendi, G., et al. (2013). Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. BioMed research international., 2013, 901821.
29. Jazedje, T., Perin, P., Czeresnia, C., et al. (2009). Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. Journal of translational medicine., 7, 46.
30. Jin, H., Bae, Y., Kim, M., et al. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. International journal of molecular sciences., 14, 17986–18001.
31. Hua J, Gong J, Meng H et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell biology international. 2013.
32. Roobrouck V, Clavel C, Jacobs S et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem cells (Dayton, Ohio). 2011;29:871–882.
33. Secco M, Zucconi E, Vieira N et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem cells (Dayton, Ohio). 2008;26:146–150.
34. Birbrair A, Zhang T, Wang Z-M et al. Role of Pericytes in Skeletal Muscle Regeneration and Fat Accumulation. Stem cells and development. 2013.
35. Lavasani, M., Robinson, A., Lu, A., et al. (2012). Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nature communications., 3, 608.